ALK and non-small cell lung carcinoma: Anaplastic lymphoma kinase (ALK) has been implicated as a key driver in several malignancies, including non-small cell lung cancer and anaplastic large cell lymphoma, through various activating mutations, fusions, and amplifications [27,28].